Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a week of radiation be enough for breast cancer?

NCT ID NCT06295744

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 40 times

Summary

This study is testing a very short course of radiation therapy for early-stage breast cancer, given over just 5 days. Researchers want to see how it affects breast appearance and patients' quality of life. 50 women who have had breast-conserving surgery will be followed for up to 5 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UW Carbone Cancer Center

    RECRUITING

    Madison, Wisconsin, 53792, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Radiation therapy (whole breast irradiation with simultaneous integrated boost)

What this could lead to

If successful, this could show that a shorter, 5-day radiation course is just as good for appearance and quality of life as longer treatments.

What could go wrong

This is a small, early-phase study with only 50 participants, so results may not apply to everyone. There are also risks of skin reactions or other side effects from radiation.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm ductal breast carcinoma in situ invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.